arrow
Back
K

Karl Hsu

rutgers university system

20H-index
47Paper Count
1.8KCitation Count
Published Papers 10
Publication Date
Case Studies for Overcoming Challenges in Using Big Data in Cancer
err2023-01-10
err2
errOAAI
errSweeney, Shawn M.; Hamadeh, Hisham K.; Abrams, Natalie; Adam, Stacey J.; Brenner, Sara; Connors, Dana E.; Davis, Gerard J.; Fiore, Louis D.; Gawel, Susan H.; Grossman, Robert L.; Hanlon, Sean E.; Hsu, Karl; Kelloff, Gary J.; Kirsch, Ilan R.; Louv, Bill; McGraw, Deven; Meng, Frank; Milgram, Daniel; Miller, Robert S.; Morgan, Emily; Mukundam, Lata; O'Brien, Thoma; Robbins, Paul; Rubin, Eric H.; Rubinstein, Wendy S.; Salmi, Liz; Schaller, Teilo H.; Shi, George; Sigman, Caroline C.; Srivastava, Sudhir
errShare
errSave
Challenges to Using Big Data in Cancer
err2023-01-10
err14
errOAAI
errSweeney, Shawn M.; Hamadeh, Hisham K.; Abrams, Natalie; Adam, Stacey J.; Brenner, Sara; Connors, Dana E.; Davis, Gerard J.; Fiore, Louis; Gawel, Susan H.; Grossman, Robert L.; Hanlon, Sean E.; Hsu, Karl; Kelloff, Gary J.; Kirsch, Ilan R.; Louv, Bill; McGraw, Deven; Meng, Frank; Milgram, Daniel; Miller, Robert S.; Morgan, Emily; Mukundan, Lata; O'Brien, Thomas; Robbins, Paul; Rubin, Eric H.; Rubinstein, Wendy S.; Salmi, Liz; Schaller, Teilo; Shi, George; Sigman, Caroline C.; Srivastava, Sudhir
errShare
errSave
Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma
err2019-03-29
err80
errOAAI
errMartin, Thomas; Strickland, Stephen; Glenn, Martha; Charpentier, Eric; Guillemin, Helene; Hsu, Karl; Mikhael, Joseph
errShare
errSave
Combination of the MEK inhibitor, pimasertib (MSC1936369B), and the PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial.
err2013-04-01
err0
PREAI
errInfante, Jeffrey R.; Gandi, Leena; Shapiro, Geoffrey; Rizvi, Naiyer; Burris, Howard A.; Bendell, Johanna C.; Baselga, Jose; Hsu, Karl; von Richter, Oliver; Locatelli, Giuseppe; Asatiani, Ekaterine; Heist, Rebecca S.
errShare
errSave
A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors
err2011-10-02
err110
errOAAI
errAtzori, Francesco; Tabernero, Josep; Cervantes, Andres; Prudkin, Ludmila; Andreu, Jordi; Rodriguez-Braun, Edith; Domingo, Amparo; Guijarro, Jorge; Gamez, Cristina; Rodon, Jordi; Di Cosimo, Serena; Brown, Holly; Clark, Jason; Hardwick, James S.; Beckman, Robert A.; Hanley, William D.; Hsu, Karl; Calvo, Emiliano; Rosello, Susana; Langdon, Ronald B.; Baselga, Jose
errShare
errSave
A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors
err2011-03-22
err55
errOAAI
errHolen, Kyle; DiPaola, Robert; Liu, Glenn; Tan, Antoinette R.; Wilding, George; Hsu, Karl; Agrawal, Nancy; Chen, Cong; Xue, Lingling; Rosenberg, Elizabeth; Stein, Mark
errShare
errSave
Interplay of Pu.1 and gatal determines myelo-erythroid progenitor cell fate in zebrafish
err2005-01-01
err345
errOAAI
errRhodes, J; Hagen, A; Hsu, K; Deng, M; Liu, TX; Look, AT; Kanki, JP
errShare
errSave
Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis
err2003-12-01
err88
errOAAI
errLiu, TX; Howlett, NG; Deng, M; Langenau, DM; Hsu, K; Rhodes, J; Kanki, JP; D'Andrea, AD; Look, AT
errShare
errSave
errShare
errSave